These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35476512)

  • 1. Allele-specific collateral and fitness effects determine the dynamics of fluoroquinolone resistance evolution.
    Liakopoulos A; Aulin LBS; Buffoni M; Fragkiskou E; van Hasselt JGC; Rozen DE
    Proc Natl Acad Sci U S A; 2022 May; 119(18):e2121768119. PubMed ID: 35476512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Landscape of Phenotypic and Transcriptional Responses to Ciprofloxacin in Acinetobacter baumannii: Acquired Resistance Alleles Modulate Drug-Induced SOS Response and Prophage Replication.
    Geisinger E; Vargas-Cuebas G; Mortman NJ; Syal S; Dai Y; Wainwright EL; Lazinski D; Wood S; Zhu Z; Anthony J; van Opijnen T; Isberg RR
    mBio; 2019 Jun; 10(3):. PubMed ID: 31186328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Ser79Leu and Ser81Ile substitutions in the quinolone resistance-determining regions of ParC topoisomerase IV and GyrA DNA gyrase subunits from recent fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
    Korzheva N; Davies TA; Goldschmidt R
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2479-86. PubMed ID: 15917550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the evolutionary trajectories of fluoroquinolone resistance in Streptococcus pneumoniae.
    Zhang G; Wang C; Sui Z; Feng J
    J Antimicrob Chemother; 2015 Sep; 70(9):2499-506. PubMed ID: 26031465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay in the selection of fluoroquinolone resistance and bacterial fitness.
    Marcusson LL; Frimodt-Møller N; Hughes D
    PLoS Pathog; 2009 Aug; 5(8):e1000541. PubMed ID: 19662169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.
    Rozen DE; McGee L; Levin BR; Klugman KP
    Antimicrob Agents Chemother; 2007 Feb; 51(2):412-6. PubMed ID: 17116668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.
    Balsalobre L; de la Campa AG
    Antimicrob Agents Chemother; 2008 Mar; 52(3):822-30. PubMed ID: 18160515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance and novel mutations detected in the gyrA and parC genes of Pseudomonas aeruginosa strains isolated from companion dogs.
    Park Y; Oh J; Park S; Sum S; Song W; Chae J; Park H
    BMC Vet Res; 2020 Apr; 16(1):111. PubMed ID: 32293442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The population genetics of collateral resistance and sensitivity.
    Ardell SM; Kryazhimskiy S
    Elife; 2021 Dec; 10():. PubMed ID: 34889185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soft sweep development of resistance in Escherichia coli under fluoroquinolone stress.
    Xie X; Lv R; Yang C; Song Y; Yan Y; Cui Y; Yang R
    J Microbiol; 2019 Dec; 57(12):1056-1064. PubMed ID: 31555989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shared and Unique Evolutionary Trajectories to Ciprofloxacin Resistance in Gram-Negative Bacterial Pathogens.
    Zlamal JE; Leyn SA; Iyer M; Elane ML; Wong NA; Wamsley JW; Vercruysse M; Garcia-Alcalde F; Osterman AL
    mBio; 2021 Jun; 12(3):e0098721. PubMed ID: 34154405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy.
    Montanari MP; Tili E; Cochetti I; Mingoia M; Manzin A; Varaldo PE
    Microb Drug Resist; 2004; 10(3):209-17. PubMed ID: 15383164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design principles of collateral sensitivity-based dosing strategies.
    Aulin LBS; Liakopoulos A; van der Graaf PH; Rozen DE; van Hasselt JGC
    Nat Commun; 2021 Sep; 12(1):5691. PubMed ID: 34584086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Mismatched PCR-Restriction Fragment Length Polymorphism Assay for Rapid Detection of
    Kakuta N; Nakano R; Nakano A; Suzuki Y; Tanouchi A; Masui T; Horiuchi S; Endo S; Kakuta R; Ono Y; Yano H
    Ann Lab Med; 2020 Jan; 40(1):27-32. PubMed ID: 31432636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Evaluation of High Fluoroquinolone Resistant Genes in Endemic Cases of Shigellosis, Northeast Part of Karnataka, India.
    C P; Desai P; R KC
    Ann Glob Health; 2016; 82(5):832-839. PubMed ID: 28283137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal antibiotic collateral sensitivity in Burkholderia multivorans.
    Kavanaugh LG; Flanagan JN; Steck TR
    Int J Antimicrob Agents; 2020 Jul; 56(1):105994. PubMed ID: 32335276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid detection of gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae by denaturing high-performance liquid chromatography.
    Shigemura K; Shirakawa T; Okada H; Tanaka K; Udaka T; Kamidono S; Arakawa S; Gotoh A
    J Microbiol Methods; 2004 Dec; 59(3):415-21. PubMed ID: 15488283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone resistance among Neisseria gonorrhoeae isolates from Shanghai, China: detection of quinolone resistance-determining region mutations.
    Tiejun Z; Xiaoming Z; Jilun Z; Yinghu Z; Yanhua R; Yue C; Weiming G; Tao Z; Qingwu J
    Indian J Med Res; 2009 Jun; 129(6):701-6. PubMed ID: 19692753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis.
    Yokoi S; Yasuda M; Ito S; Takahashi Y; Ishihara S; Deguchi T; Maeda S; Kubota Y; Tamaki M; Fukushi H
    J Infect Chemother; 2004 Oct; 10(5):262-7. PubMed ID: 16163459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.